Therapeutic potential of new Pt(II) and Ru(III) triazole-pyrimidine complexes against Leishmania donovani

Pharmacology

Volumn 73, Issue 1, 2005, Pages 41-48

  Magán, Rosa ^a   Marín, Clotilde ^a   Rosales, María Jose ^a   Salas, Juan Manuel ^a   Sánchez Moreno, Manuel ^a  

^a UNIVERSITY OF GRANADA   (Spain)

Author keywords

L. donovani, in vitro promastigote forms; Leishmania donovani; Triazole pyrimidine derivatives; Triazole pyrimidine, antiprotozoal

Indexed keywords

ACETIC ACID; AMPHOTERICIN B; ANTIPROTOZOAL AGENT; CARBON DIOXIDE; GLUCOSE; PLATINUM DERIVATIVE; PYRIMIDINE DERIVATIVE; RUTHENIUM COMPLEX; TRIAZOLE DERIVATIVE;

AMASTIGOTE; ANIMAL CELL; ANTIPROTOZOAL ACTIVITY; ARTICLE; CELL ORGANELLE; CELL ULTRASTRUCTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG POTENCY; FEMALE; LEISHMANIA DONOVANI; MACROMOLECULE; NONHUMAN; PARASITE DEVELOPMENT; PRIORITY JOURNAL; PROMASTIGOTE; PROTEIN SYNTHESIS INHIBITION; RAT; RNA SYNTHESIS;

ANIMALS; CELL SURVIVAL; CELLS, CULTURED; DNA; GLYCOLYSIS; LEISHMANIA DONOVANI; MACROPHAGES; MICE; MICE, INBRED BALB C; MICROSCOPY, ELECTRON; ORGANOPLATINUM COMPOUNDS; PYRIMIDINES; RNA; RUTHENIUM COMPOUNDS; TRIAZOLES;

EID: 10844234671     PISSN: 00317012     EISSN: None     Source Type: Journal    
DOI: 10.1159/000081073     Document Type: Article

References (20)

1. Anom J: World Health Organization. Inf. Circ. WHO Mediterr. Zoon Control. Cent 1996;40:11.
2. Molyneux DH: Current public health status of the trypanosomiases and leishmaniases; in Hide G, Mottram JC, Coombs GH, Holmes PH (eds): Trypanosomiasis and Leishmaniasis. Wallingford, CAB International, 1997, pp 39-50.
3. Herwaldt BL: Leishmaniasis. Lancet 1999;354:1191-1199.
4. Murray HW, Pépin J, Nutman TB, Hoffman SL, Mahmoud AF: Tropical medicine. BMJ 2000;320:490-494.
5. Sundar S, Gupta B, Makharia MK, Singh MK, Voss A, Rosenkaimer F, Engel J, Murray HW: Oral treatment of visceral leishmaniasis with miltefosine. Ann Trop Med Parasitol 1999;93:589-597.
6. Sharifi I, Fekri AR, Aflatonian MR, Khamesipour A, Nadim A, Mousavi MRA, Momeni AZ, Dowlati Y, Godal T, Zicker F, Smith PG, Modabber F: Randomized vaccine trial of single-dose of killed Leishmania major plus BCG against anthroponotic cutaneous leishmaniasis in Bam, Iran. Lancet 1998;351:1540-1543.
7. Hide G, Mottram JC, Coombs GH, Holmes PH: Preface: Current research into the biology and control of trypanosomiasis and leishmaniasis; in Hide G, Mottram JC, Coombs GH, Holmes PH (eds): Trypanosomiasis and Leishmaniasis. Wallingford, CAB International, 1997, pp 53-58.
8. Luque F, Fernández-Ramos C, Entrala E, Rosales MJ, Navarro, JA, Romero MA, Salas-Peregrín JM, Sánchez-Moreno M: In vitro evaluation of newly synthesised [1,2,4]triazolo[ 1,5a]pyrimidine derivatives against Trypanosoma cruzi, Leishmania donovani and Phytomonas staheli. Comp Biochem Physiol 2000;126:39-44.
9. Luque F, Fernández-Ramos C, Entrala E, Rosales MJ, Marín C, Salas JM, Navarro JA, Sánchez-Moreno M:. Biochemical and ultrastructural alterations caused by newly synthesized 1, 2, 4-triazole [1,5a] pyrimidine derivatives against Phytomonas staheli (Trypanosomatidae). Toxicol In Vitro 2000;14:487-495.
10. Magan R, Marín C, Rosales MJ, Barrera MA, Salas JM, Sánchez-Moreno M: Activities of Pt (II) and Ru (III) triazole-pyrimidine complexes against Trypanosoma cruzi and Trypanosoma brucei brucei. Pharmacology 2004;70:83-90.
11. Fischer G: 1,2,4-Triazole(1,5-α)pyrimidines. Adv Heterocycl Chem 1993;57:81-86.
12. Woerdenbag HJ, Merfort I, Passreiter CM, Schmidt TJ, Willuhn G, Vanuden W, Pras N, Kampinga HH, Konings AWT: Cytotoxicity of flavonoids and sesquiterpene lactones from arnica species against the GLC(4) and the colo-320 cell lines. Planta Med 1994;60:434-437.
13. Chae MY, Swenn K, Kanugul S, Dolan ME, Pegg AE, Moschel RC: 8-Substituted O-6-benzylguanine, substituted 6(4)-(benzyloxy) pyrimidine, and related derivatives as inactivators of human O-6-alkylguanine-DNA alkyltransferase. J Med Chem 1995;38:359-365.
14. a) adenosine antagonists. J Med Chem 1996;39:1164-1171.
15. 3 (edelfosine and amphotericin B). Acta Trop 2002;81:151-157.
16. Mesa-Valle CM, Castilla-Calvente J, Sánchez-Moreno M, Moraleda-Lindez V, Barbe J, Osuna A: Activity and mode of action of acridine compounds against Leishmania donovani. Antimicrob Agents Chemother 1996;40:684-690.
17. Sánchez-Moreno M, Lasztity D, Coppens I, Opperdoes FR: Characterization of carbohydrate metabolism and demonstration of glycosomes in a Phytomonas sp. isolated from Euphorbia characias. Mol Biochem Parasitol 1992;54:185-200.
18. Beekman AC, Woerdenbag HJ, Vanuden W, Pras N, Konings AWT, Wikstrom HV, Schmidt TJ: Structure-cytotoxicity relationships of some helenanolide-type sesquiterpene lactones. J Nat Prod 1997;60:252-257.
19. Castanys S, Osuna A, Gamarro F, Ruiz-Perez LM: Purification of metacyclic forms of Trypanosoma cruzi by Percoll discontinuous gradient centrifugation. Z Parasitenkd 1984;70:443-449.
20. Blum JJ: Intermediary metabolism of Leishmania. Parasitol Today 1993;9:118-122.